Head to head for first-timers
CoreAge Rx vs He and She MD
CoreAge Rx and He and She MD both offer GLP-1 telehealth, but they make different trade-offs on how gentle the start is, honest pricing, real support and access. Here they are side by side on the Mama-Match Score — our first-timer rubric.
CoreAge Rx
Higher scoreRank #32 for first-timers · Grade C
Mama-Match
Best for: Someone comparing dose prices who can obtain the offer, state availability and order terms in writing.
Visit CoreAge RxHe and She MD
Rank #109 for first-timers · Grade C
Mama-Match
Best for: Moms who want brand-name and oral options alongside compounded on one platform, and who will either pay $199/mo month-to-month or prepay a year to reach $99.
Visit He and She MDThe verdict for a first step
CoreAge Rx edges out He and She MD on the Mama-Match Score, 73 to 60 (C vs C). Someone comparing dose prices who can obtain the offer, state availability and order terms in writing.
He and She MD is still a genuine option — $199/mo semaglutide, $299/mo tirzepatide month-to-month, dropping to $99 and $159 only on a full year prepaid. It names its pharmacies, its clinical group and its CMO. Weigh the six first-timer factors below against your own priorities.
Side by side on all six factors
Both providers judged on the same first-timer rubric — the higher side on each factor is marked. See the methodology.
Price, access and features
| Detail | CoreAge Rx | He and She MD |
|---|---|---|
| Mama-Match Score | 73/100 · C | 60/100 · C |
| Overall rank | #32 | #109 |
| Semaglutide | $99/mo | $199/mo month-to-month, $99/mo on the 12-month plan |
| Tirzepatide | $149/mo | $299/mo month-to-month, $159/mo on the 12-month plan |
| Coverage | Therapy-specific state restrictions; confirm eligibility | 49 states — everywhere except Louisiana |
| Brand-name access | Compounded only | Yes |
| Oral / sublingual | Injection only | Yes |
Mama-Match
CoreAge Rx
Rank #32 · Grade C
What we like
- Published prices for both molecules, with the same advertised amount at each dose
- The offer includes medication, consultation and shipping, without an advertised membership fee
- The legal footer identifies the platform and the entities responsible for clinical care
The caveats
- The main site and a separate offer page show different prices
- The FAQ and policy differ on automatic rebilling and denial refunds
- State restrictions; orders become final when sent to pharmacy, with a 30-day refund cutoff
Mama-Match
He and She MD
Rank #109 · Grade C
What we like
- A genuinely broad menu — compounded injectable, compounded oral, and FDA-approved brand (Ozempic, Zepbound) for both molecules, all priced on one platform
- Both month-to-month rates are published now ($199 semaglutide, $299 tirzepatide), so you can see what not committing actually costs — most of this roster shows only the prepay figure
- Names its pharmacies, its clinical group (Wasef Health PC) and its chief medical officer (Dr. Ozita Cooper, MD, dual board-certified in obesity medicine) — most of this roster names none of the three
The caveats
- The 6-month tiers are introductory: semaglutide's $139/mo renews at $199/mo and tirzepatide's $199/mo at $289/mo, and the plans page shows the discount without the renewal
- The lowest advertised prices need 12 months paid up front — $1,188 for semaglutide, $1,908 for tirzepatide, in a single charge
- GLP-1s do not ship to Louisiana, which the FAQ states plainly and the rest of the site's 'nationwide' framing does not
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Mama-Match Score. Prices, states and verification reflect what each provider disclosed publicly at our last review; the Mama-Match Score is our editorial judgment under the methodology. Prices change — confirm them on each provider’s site. Not medical advice; see our disclosure.
More head-to-heads
Keep comparing CoreAge Rx and He and She MD with the other providers we review for women.
Or browse the full comparison hub.